In recent years, there have been a number of technological breakthroughs that have allowed for clinical trials in gent therapy to be initiated. In combination with the genome initiative, the potential for new therapeutics is limitless. Although an enormous amount of information has been obtained in a relatively short period of time, gene therapy is not yet ready for wide- scale practice. Some of the successes and obstacles that remain are summarized in this report.
|Tijdschrift||Proceedings of the National Academy of Sciences of the United States of America|
|Nummer van het tijdschrift||24|
|Status||Gepubliceerd - 25 nov. 1997|